All lobbying filings

The KPM Group DC LLC

The KPM Group DC LLC filed a Q1 report for Sebela Pharmaceuticals on April 21, 2025, reporting $40,000 in lobbying income.

Lobbying for Sebela Pharmaceuticals · Developing therapies for gastrointestinal diseases and women's health

As filed: THE KPM GROUP DC LLC for SEBELA PHARMACEUTICALS.

All filings by The KPM Group DC LLC · Everything Sebela Pharmaceuticals has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Discussed the need for Congressional oversight of CMS to ensure enforcement of the preventive services mandate, specifically requiring coverage of bowel preparation medications without cost-sharing when used for colonoscopy screenings.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.